BR9710544A - M-todo de tratamento composto e composi-Æo farmac-utica - Google Patents

M-todo de tratamento composto e composi-Æo farmac-utica

Info

Publication number: BR9710544A
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; treatment method; composite treatment; composite; pharmaceutical
Prior art date: 1996-07-24

Application number

BR9710544A

Other languages

English (en)

Portuguese (pt)

Inventor

Argyrios Georgious Arvanitis

Robert John Chorvat

Paul Joseph Gilligan

Liqui He

Original Assignee

Du Pont Pharm Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-24

Filing date

1997-07-23

Publication date

1999-08-17

1997-07-23 Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co

1997-07-23 Priority claimed from PCT/US1997/013072 external-priority patent/WO1998003510A1/en

1997-07-23 Priority claimed from US08/899,242 external-priority patent/US6124289A/en

1999-08-17 Publication of BR9710544A publication Critical patent/BR9710544A/pt

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US2329096P	1996-07-24	1996-07-24
US68604796A	1996-07-24	1996-07-24
PCT/US1997/013072 WO1998003510A1 (en)	1996-07-24	1997-07-23	Azolo triazines and pyrimidines
US08/899,242 US6124289A (en)	1996-07-24	1997-07-23	Azolo triazines and pyrimidines

Publications (1)

Publication Number	Publication Date
BR9710544A true BR9710544A (pt)	1999-08-17

Family

ID=27362048

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9710544A BR9710544A (pt)	1996-07-24	1997-07-23	M-todo de tratamento composto e composi-Æo farmac-utica

Country Status (15)

Country	Link
JP (2)	JP4704521B2 (zh)
CN (3)	CN1104432C (zh)
AR (1)	AR049583A2 (zh)
BR (1)	BR9710544A (zh)
CA (1)	CA2259583C (zh)
CZ (1)	CZ299451B6 (zh)
EA (1)	EA004403B1 (zh)
EE (1)	EE04316B1 (zh)
HR (1)	HRP970413A2 (zh)
IL (4)	IL127871A0 (zh)
NO (1)	NO315610B1 (zh)
NZ (1)	NZ333777A (zh)
PL (1)	PL195762B1 (zh)
SI (1)	SI9720045B (zh)
SK (1)	SK286461B6 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030125330A1 (en) *	2001-03-13	2003-07-03	Gilligan Paul J.	4 - (2-butylamino) - 2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-yl) pyrazolo- [1,5-A] - 1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
WO2004110454A1 (ja) *	2003-06-13	2004-12-23	Ishihara Sangyo Kaisha, Ltd.	アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
US7329662B2 (en) *	2003-10-03	2008-02-12	Hoffmann-La Roche Inc.	Pyrazolo-pyridine
GB0519957D0 (en) *	2005-09-30	2005-11-09	Sb Pharmco Inc	Chemical compound
AU2007297421B2 (en) *	2006-09-20	2012-03-08	Eli Lilly And Company	Thiazole pyrazolopyrimidines as CRF1 receptor antagonists
CN103694242B (zh) *	2013-12-10	2016-01-06	昆明翔昊科技有限公司	吡唑并嘧啶类化合物及其药物组合物和其在制药中的应用
CN110996943A (zh)	2017-08-14	2020-04-10	云杉生物科学公司	促肾上腺皮质激素释放因子受体拮抗剂
CN112500416B (zh) *	2019-07-30	2021-12-17	厦门宝太生物科技股份有限公司	一种吡唑并三嗪类化合物中间体的制备方法
KR20240023691A (ko)	2020-08-12	2024-02-22	스프루스 바이오사이언시스 인코포레이티드	다낭성 난소 증후군을 치료하기 위한 방법 및 조성물
US11708372B2 (en)	2021-11-19	2023-07-25	Spruce Biosciences, Inc.	Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3995039A (en) *	1975-05-27	1976-11-30	Merck & Co., Inc.	Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (ja) *	1984-08-29	1986-03-24	Shionogi & Co Ltd	縮合複素環誘導体および抗潰瘍剤
US4824834A (en) *	1986-10-31	1989-04-25	Otsuka Pharmaceutical Company, Limited	Pyrazolotriazine compounds
JP2691317B2 (ja) *	1989-08-25	1997-12-17	株式会社大塚製薬工場	４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法
EP0503099A4 (en) *	1990-10-09	1993-12-01	Otsuka Pharmaceutical Co., Ltd.	Pyrimidine derivative, production thereof, and androgen inhibitor
KR100191774B1 (ko) *	1991-04-22	1999-06-15	오스카 아끼히꼬	피라졸로[1,5-알파] 피리미딘 유도체 및 이것을 함유하는 항염증제
US5356897A (en) *	1991-09-09	1994-10-18	Fujisawa Pharmaceutical Co., Ltd.	3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

1997
- 1997-07-23 CA CA002259583A patent/CA2259583C/en not_active Expired - Lifetime
- 1997-07-23 EE EEP199900019A patent/EE04316B1/xx unknown
- 1997-07-23 SK SK97-99A patent/SK286461B6/sk not_active IP Right Cessation
- 1997-07-23 PL PL97331523A patent/PL195762B1/pl unknown
- 1997-07-23 IL IL12787197A patent/IL127871A0/xx unknown
- 1997-07-23 CZ CZ0018499A patent/CZ299451B6/cs not_active IP Right Cessation
- 1997-07-23 BR BR9710544A patent/BR9710544A/pt not_active IP Right Cessation
- 1997-07-23 JP JP50723398A patent/JP4704521B2/ja not_active Expired - Fee Related
- 1997-07-23 CN CN97196525A patent/CN1104432C/zh not_active Expired - Lifetime
- 1997-07-23 SI SI9720045A patent/SI9720045B/sl active Search and Examination
- 1997-07-23 EA EA199900158A patent/EA004403B1/ru not_active IP Right Cessation
- 1997-07-23 NZ NZ333777A patent/NZ333777A/en not_active IP Right Cessation
- 1997-07-24 HR HRP970413 patent/HRP970413A2/hr not_active Application Discontinuation
1998
- 1998-12-30 IL IL127871A patent/IL127871A/en not_active IP Right Cessation
1999
- 1999-01-21 NO NO19990264A patent/NO315610B1/no not_active IP Right Cessation
2001
- 2001-05-30 CN CN 01120849 patent/CN1250223C/zh not_active Expired - Lifetime
2002
- 2002-04-25 CN CN 02118589 patent/CN1388126A/zh active Pending
- 2002-06-11 IL IL150163A patent/IL150163A/en not_active IP Right Cessation
2004
- 2004-07-23 JP JP2004216483A patent/JP4194539B2/ja not_active Expired - Fee Related
- 2004-10-12 IL IL164513A patent/IL164513A/en not_active IP Right Cessation
2005
- 2005-07-11 AR ARP050102868A patent/AR049583A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
SI9720045B (sl)	2008-02-29
NO315610B3 (no)	2003-09-29
IL127871A0 (en)	1999-10-28
CA2259583A1 (en)	1998-01-29
NO990264L (no)	1999-03-10
NZ333777A (en)	2000-07-28
HRP970413A2 (en)	1998-10-31
CZ299451B6 (cs)	2008-07-30
CA2259583C (en)	2009-11-17
CN1225637A (zh)	1999-08-11
EA199900158A1 (ru)	1999-10-28
CZ18499A3 (cs)	1999-11-17
JP2005097257A (ja)	2005-04-14
IL164513A0 (en)	2005-12-18
EE9900019A (et)	1999-08-16
NO315610B1 (no)	2003-09-29
CN1327793A (zh)	2001-12-26
AR049583A2 (es)	2006-08-16
EA004403B1 (ru)	2004-04-29
CN1104432C (zh)	2003-04-02
JP2002513382A (ja)	2002-05-08
SK286461B6 (sk)	2008-10-07
NO990264D0 (no)	1999-01-21
SI9720045A (sl)	1999-10-31
JP4704521B2 (ja)	2011-06-15
IL127871A (en)	2010-04-29
CN1250223C (zh)	2006-04-12
EE04316B1 (et)	2004-06-15
CN1388126A (zh)	2003-01-01
PL331523A1 (en)	1999-07-19
PL195762B1 (pl)	2007-10-31
JP4194539B2 (ja)	2008-12-10
SK9799A3 (sk)	2005-04-01
IL164513A (en)	2010-04-29
IL150163A (en)	2010-12-30

Similar Documents

Publication	Publication Date	Title
BR9407799A (pt)	1997-05-06	Composição de matéria método de tratamento e composição farmaceutica
BR9609132A (pt)	1999-08-17	Composicão e método de tratamento de semente
DE69737795D1 (de)	2007-07-19	Zusammengesetztes bauelement und wandkonstruktionsverfahren
FI972164L (fi)	1997-07-21	Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
FI972165L (fi)	1997-07-21	Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
DE69721286D1 (de)	2003-05-28	Befestigungsvorrichtung sowie anwendungsverfahren dafür
EE9800234A (et)	1998-12-15	Ravimeetod ja farmatseutiline kompositsioon
EE04681B1 (et)	2006-08-15	3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
FI951060L (fi)	1995-09-09	Formulaatioita ja hoitomenetelmiä
FI964869L (fi)	1997-10-05	Paikannusmenetelmä ja järjestelmä
BR9710379A (pt)	1999-08-17	Material decorativo de tit-nio e m-todo de endurecimento para o mesmo
FI972235L (fi)	1997-05-27	Menetelmä triaryylietyleenijohdannaisten käyttämiseksi osteoporoosin hoidossa ja ehkäisyssä
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
BR9710544A (pt)	1999-08-17	M-todo de tratamento composto e composi-Æo farmac-utica
PT932400E (pt)	2003-03-31	Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
DE69514960D1 (de)	2000-03-16	Schlackbehandlungssystem und -methode
FI972988A0 (fi)	1997-07-14	Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
BR9700362A (pt)	1998-11-03	Cilindro intermediário conjunto de srlo esistema transportador
DE69718502D1 (de)	2003-02-20	Zahnärztliche zusammensetzung, system und verfahren
FR2746261B1 (fr)	1998-05-07	Composition insecticide et procede de preparation
BR9707332A (pt)	1999-07-20	Método e formulação de revestimento de cura dupla
FI953391L (fi)	1996-01-13	Komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
ID19437A (id)	1998-07-09	Pengolahan dan komposisi untuk pengobatan anti-parasit di sekeliling tempat hewan-hewan
BR9612503A (pt)	1999-07-20	Codificador auto-inicializado e método do mesmo
DE69524527D1 (de)	2002-01-24	AIDS-hemmende Arzneizubereitung und Verfahren

Legal Events

Date	Code	Title	Description
2002-01-29	TE	Change of address
2004-06-29	B25D	Requested change of name of applicant approved
2004-06-29	B25G	Requested change of headquarter approved
2007-07-03	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2008-02-26	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2008-09-16	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AOS ARTIGOS 24 E 25 DA LEI 9.279/96
2009-08-04	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2017-09-12	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-01-02	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]